noromectin 1.87% pasta oral para cavalos
norbrook laboratories ltd (irlanda) - ivermectina 18.7 mg/g - pasta oral - ivermectina - equinos
maximec, 18,7 mg/g pasta oral para equinos
bimeda animal health ltd. - ivermectina 18.7 mg - pasta oral - ivermectina - equinos
clindaseptin 150mg cápsulas para cães
chanelle pharmaceuticals manufacturing ltd. - clindamicina 150.0 mg - cápsula - clindamicina - caninos (cães)
clindaseptin 25 mg cápsulas para cães
chanelle pharmaceuticals manufacturing ltd. - clindamicina 25.0 mg - cápsula - clindamicina - caninos (cães)
clindaseptin 300 mg cápsulas para cães
chanelle pharmaceuticals manufacturing ltd. - clindamicina 300.0 mg - cápsula - clindamicina - caninos (cães)
clindaseptin 75 mg cápsulas para cães
chanelle pharmaceuticals manufacturing ltd. - clindamicina 75.0 mg - cápsula - clindamicina - caninos (cães)
terramicina 100 mg/ml solução injetável para bovinos, ovinos, caprinos, suínos e equinos.
zoetis portugal, lda - cloridrato de oxitetraciclina 100.0 mg - solução injetável - oxitetraciclina - bovinos, caprinos, equinos, ovinos, suínos
abasaglar (previously abasria)
eli lilly nederland b.v. - insulina glargine - diabetes mellitus - drogas usadas em diabetes - tratamento de diabetes mellitus em adultos, adolescentes e crianças com idade igual ou superior a 2 anos.
acomplia
sanofi-aventis - rimonabant - obesidade - preparados antiobesidade, excl. produtos dietéticos - como adjuvante à dieta e ao exercício para o tratamento de pacientes obesos (imc 30 kg/m2), ou pacientes com sobrepeso (imc de 27 kg/m2) com o fator de risco associado(s), tais como diabetes tipo 2 ou dyslipidaemia (consulte a secção 5.
adcetris
takeda pharma a/s - brentuximab vedotin - lymphoma, non-hodgkin; hodgkin disease - agentes antineoplásicos - hodgkin lymphomaadcetris is indicated for adult patients with previously untreated cd30+ stage iv hodgkin lymphoma (hl) in combination with doxorubicin, vinblastine and dacarbazine (avd). adcetris is indicated for the treatment of adult patients with cd30+ hl at increased risk of relapse or progression following autologous stem cell transplant (asct). adcetris is indicated for the treatment of adult patients with relapsed or refractory cd30+ hodgkin lymphoma (hl):following asct, orfollowing at least two prior therapies when asct or multi-agent chemotherapy is not a treatment option. systemic anaplastic large cell lymphomaadcetris in combination with cyclophosphamide, doxorubicin and prednisone (chp) is indicated for adult patients with previously untreated systemic anaplastic large cell lymphoma (salcl). adcetris is indicated for the treatment of adult patients with relapsed or refractory salcl. cutaneous t cell lymphomaadcetris is indicated for the treatment of adult patients with cd30+ cutaneous t cell lymphoma (ctcl) after at least 1 prior systemic therapy.